Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT06454409 · SUSPENDED

Trial details

NCT number: NCT06454409
Sponsor: City of Hope Medical Center
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome/Acute Myeloid Leukemia Recurrent Acute Myeloid Leukemia Recurrent Myelodysplastic Syndrome Refractory Acute Myeloid Leukemia Refractory Myelodysplastic Syndrome

Start date: 2025-05-21
Primary completion: 2030-09-06
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.